Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-03-01 @ 5:17 PM
Study NCT ID:
NCT02362035
Status:
COMPLETED
Last Update Posted:
2025-12-11
First Post:
2015-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
Sponsor:
Acerta Pharma BV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACE-LY-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |